Skip to content

Spinal cord electrical stimulation for post-stroke hemiparesis

A prospective, single-center, single-arm historical controlled study of spinal cord electrical stimulation for the treatment of hemiparesis after stroke

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500105120
Enrollment
Unknown
Registered
2025-06-30
Start date
2025-07-01
Completion date
Unknown
Last updated
2025-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post-stroke hemiplegia

Interventions

Test group:electrical spinal cord stimulation

Sponsors

The First Affiliated Hospital of Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Be between 18 and 65 years of age; 2. Suffered from ischemic or hemorrhagic stroke with hemiparesis combined or uncomplicated pain more than six months prior to the start of the study; 3. Fugl-Meyer motor function score greater than 11 and less than 75. 4. Stable primary condition, stable vital signs, no cervical spine and brain stem injury, no previous serious renal function abnormality, liver function abnormality and brain disease, no coagulation abnormality, no clear cardiorespiratory dysfunction, able to accept surgical treatment, no clear contraindication; 5. The patient or family members are informed and sign an informed consent form;

Exclusion criteria

Exclusion criteria: 1. Serious illness or disorder (e.g., tumor, heart or respiratory disease, kidney failure, etc.) or cognitive impairment that may interfere with participation in learning activities; 2. Pregnancy or breastfeeding; 3. Joint contractures that are considered by the clinician/investigator to be too severe to participate in the study activities; 4. Comorbid other problems of the brain, such as hydrocephalus requiring surgical management, epilepsy, severe cerebral edema and intracranial infections, previous diagnosis of neurodegenerative diseases, dementia, and severe psychiatric disorders; 5. There is definite organ failure, or other problems affecting the patient's life expectancy, with a life expectancy of less than 5 years; 6. Other pacemaker-type products have been implanted in the body, such as cardiac pacemakers; 7. Other movement disorders, spinal cord lesions, fractures, osteoarthritis, amputation, scoliosis and other diseases that affect movement;

Design outcomes

Primary

MeasureTime frame
Values of change in Fugl-meyer motor function score;

Secondary

MeasureTime frame
Discomfort and pain;Minimum Mental State Examination Score;adverse event;Value of change in verbal functioning scores;Motion capture (gait analysis);

Countries

China

Contacts

Public ContactChen Tunan

The First Affiliated Hospital of Army Medical University

ctn@tmmu.edu.cn+86 151 1198 6606

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026